BMI View: Japan’s pharmaceutical market is highly attractive to both foreign and local drugmakers. All three sub-sectors – patented, generic and over-the-counter (OTC) medicines – are large and forecast to growth over the medium term. Regulations are well-developed, transparent and improving. ...

more

BMI View: While the increased consumption of generic medicines will have an impact on the overall pharmaceutical market forecast for Germany, we note that government measures such as the three-year freeze on price rises for prescription drugs, as well as the implementation of mandatory ...

more

BMI View: Increased investment in private healthcare infrastructure across the Gulf Cooperation Council (GCC) region will increase standards of care, making it a more appealing destination for medical tourists. However, BMI is concerned that the sudden influx of capital into private ...

more

BMI View: The reduction in healthcare subsidies for permanent residents (PRs) in Singapore, which is to be implemented in two phases over the coming 12 months, is a politically driven move rather than a genuine restructuring of the public healthcare system. The policy also fails to address ...

more

BMI View: While the increased consumption of generic medicines will have an impact on the overall pharmaceutical market forecast for Germany, we note that government measures such as the three-year freeze on price rises for prescription drugs, as well as the implementation of mandatory ...

more

BMI View: We stand by our negative forecast for the Croatian pharmaceutical market in 2012, on the back of the weakening economy and wide-ranging cost-containment measures that will affect public sector funding. Generally speaking, the performance of Croatia’s pharmaceutical, healthcare and ...

more

BMI sees Peru as a regional outperformer in 2011, given the country's strong real GDP growth and the introduction of tax reforms which place it in a relatively strong fiscal position to provide key support for the economy in the long term. In Q310, income tax revenue increased by 26.6% ...

more

Genolier Swiss Medical Network SA (Genolier Swiss) is the leading hospital network in the French speaking region of Switzerland (Romandie). It is specialized in operating private clinics. Its growth strategy is focused on building a national network by acquiring clinics and restructuring ...

more

VIA Pharmaceuticals, Inc. (VIA) is a public traded biotechnology company engaged in discovery, development and commercialization of drugs for the treatment of cardiovascular and metabolic disease. The company's product line includes, VIA-2291 is a selective and reversible inhibitor of 5LO ...

more

Sun Healthcare Group, Inc. (Sun Healthcare) is a healthcare company based in the US. Sun Healthcare is principally engaged in providing nursing, rehabilitative and related specialty healthcare services to the senior population in the US. The company provides essential services, including ...

more